Rocket Pharmaceuticals (RCKT) Insider Trading & Ownership

$20.17

-1.19 (-5.57%)

(As of 09/20/2024 ET)

Current Insider Ownership Percentage: 31.10%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 7
Amount Of Insider Selling (Last 12 Months): $12.53 M

Get RCKT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rocket Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RCKT Insider Buying and Selling by Quarter

Ad Behind the Markets

The $15 "Insider Secret" That Could Save Your Retirement

What if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's right. You can grab shares of this potential retirement-maker for less than you'd pay for lunch.

Click here to discover the name and ticker of this "$15 billionaire-backed retirement stock" >>>

Rocket Pharmaceuticals Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
7/22/2024	John Militello	Insider	Sell	812	$23.02	$18,692.24
7/8/2024	Mark Andrew White	Insider	Sell	3,026	$20.39	$61,700.14
5/16/2024	Gaurav Shah	CEO	Sell	9,790	$23.35	$228,596.50
5/16/2024	John Militello	Insider	Sell	1,079	$23.35	$25,194.65
5/16/2024	Martin Wilson	General Counsel	Sell	1,048	$23.35	$24,470.80
4/22/2024	John Militello	Insider	Sell	833	$22.87	$19,050.71
War on Elon Escalates… (Ad) One company holds a near-total monopoly on this technology. Elon Musk is one of the few people who knows this. That’s why in his recent interview with Trump, he brought up this technology as a viable solution to America’s growing energy needs. What is this technology and why has it put Elon in the middle of an ideological war with the elites? Watch my new exposé and find out.
4/15/2024	David P Southwell	Director	Sell	10,000	$24.05	$240,500.00
4/12/2024	David P Southwell	Director	Sell	70,000	$24.36	$1,705,200.00
4/8/2024	Mark Andrew White	Insider	Sell	12,532	$24.64	$308,788.48
3/21/2024	Gotham Makker	Director	Sell	274,000	$28.43	$7,789,820.00
3/21/2024	John Militello	Insider	Sell	2,490	$28.10	$69,969.00
2/29/2024	John Militello	Insider	Sell	10,000	$29.84	$298,400.00
2/29/2024	Martin Wilson	General Counsel	Sell	4,100	$29.33	$120,253.00
2/16/2024	Gaurav Shah	CEO	Sell	20,272	$29.84	$604,916.48
2/16/2024	Kinnari Patel	Insider	Sell	7,132	$29.84	$212,818.88
2/16/2024	Martin Wilson	General Counsel	Sell	3,576	$29.84	$106,707.84
1/22/2024	John Militello	Insider	Sell	638	$27.20	$17,353.60
11/15/2023	Gotham Makker	Director	Sell	20,000	$22.53	$450,600.00
10/20/2023	John Militello	Insider	Sell	564	$17.06	$9,621.84
9/28/2023	Gotham Makker	Director	Sell	10,312	$21.03	$216,861.36

(Data available from 1/1/2013 forward)

RCKT Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Rocket Pharmaceuticals includes David P Southwell, Gaurav Shah, Gotham Makker, John Militello, Jonathan David Schwartz, Kinnari Patel, Mark Andrew White, Martin Wilson, and Rtw Investments, Lp. Learn more on insiders at RCKT.
: 31.10% of Rocket Pharmaceuticals stock is owned by insiders. Learn more on RCKT's insider holdings.
: The following insider purchased RCKT shares in the last 24 months: Rtw Investments, Lp ($19,999,997.00).
: Insiders have purchased a total of 1,355,932 RCKT shares in the last 24 months for a total of $19,999,997.00 bought.
: The following insiders have sold RCKT shares in the last 24 months: David P Southwell ($1,945,700.00), Gaurav Shah ($1,139,676.11), Gotham Makker ($8,457,281.36), John Militello ($512,864.53), Jonathan David Schwartz ($67,796.42), Kinnari Patel ($236,549.86), Mark Andrew White ($370,488.62), and Martin Wilson ($251,431.64).
: Insiders have sold a total of 487,171 Rocket Pharmaceuticals shares in the last 24 months for a total of $12,981,788.54 sold.

Rocket Pharmaceuticals Key Executives

Ms. Kinnari Patel M.B.A. (Age 44)
Pharm.D., Head of R&D, President & COO
Compensation: $849.93k
Mr. Mayo Pujols (Age 54)
Chief Technical Officer
Compensation: $649.71k
Mr. Raj Prabhakar M.B.A. (Age 49)
Chief Business Officer
Compensation: $619.13k
Mr. Aaron Ondrey (Age 47)
Chief Financial Officer
Mr. Martin Louis Wilson J.D. (Age 48)
General Counsel, Chief Compliance Officer & Chief Corporate Officer
Compensation: $149.95k
Kevin Giordano
Director of Corporate Communications
Ms. Isabel Carmona J.D.
Chief People Officer
Mr. Jonathan Schwartz M.D. (Age 59)
Chief Medical & Gene Therapy Officer
Compensation: $557.79k
Dr. Gayatri R. Rao J.D.
M.D., Senior VP of Clinical Safety & Chief Regulatory Officer
Mr. Carlos Martin
Chief Commercial Operations & Revenue Officer